Last reviewed · How we verify
NCT03959995: ACTLIFE
Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia
NA trial testing High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT) in Osteopenia, Osteoporosis in 27 participants. Completed in 5 June 2020.
13 March 2020
Quick facts
| Lead sponsor | University of Erlangen-Nürnberg Medical School |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 15 January 2019 |
| Primary completion | 13 March 2020 |
| Estimated completion | 5 June 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT)
- Wellness
Conditions studied
- Osteopenia, Osteoporosis — all drugs for Osteopenia, Osteoporosis →
Sponsor
University of Erlangen-Nürnberg Medical School
Who can join
Adults 48 to 58, female only, with Osteopenia, Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Menopause usually have a serious impact on a woman's life, associated with negative consequences for health and quality of life. Early preventive assessments are very difficult to implement due to the complex hormone-deficiency-induced effects on a large variety of organs and systems with estrogen receptors. In fact, only a few types of interventions have the potential to comprehensively improve the various risk factors and complaints of the menopausal transition. In detail, however, not every form of exercise training or every training protocol is effective for exerting positive effects on selected risk factors. In particular, the training concept for addressing musculoskeletal or cardio-metabolic risk factors differ fundamentally. In several studies, we confirmed the effect of different complex training programs on risk factors of different postmenopausal female cohorts with special consideration of osteoporotic aspects. The training programs applied in this context were characterized by the consistent implementation of recognized training principles and an in general exercise intensity-oriented approach. Recent studies confirmed the effectiveness of this proceeding for women with relevant postmenopausal risk factors including low bone strength. However, the crucial issue of the most effective, feasible and easily customizable training protocol for addressing postmenopausal risk factors remains to be answered, taking into account that the majority of exercise programs were realized in an ambulatory group setting. The aim of the study will be to evaluate the effects of an optimized physical training on risk factors and complaints of (early) postmenopausal women with special consideration of the osseous fracture risk. Note (05.06.2020): Of importance, the intervention has to be cancelled due to COVID-19 lockdown in March 2020 after 13 months of intervention.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Changes in Menopausal Risk Factors in Early Postmenopausal Osteopenic Women After 13 Months of High-Intensity Exercise: The Randomized Controlled ACTLIFE-RCT.
Hettchen M, von Stengel S, Kohl M, Murphy MH, et al · · 2021 · cited 32× · PMID 33469276 · DOI 10.2147/cia.s283177 -
Impact of 3 months of detraining after high intensity exercise on menopause-related symptoms in early postmenopausal women - results of the randomized controlled actlife project.
Jungmann S, Hettchen M, Kohl M, Kemmler W. · · 2022 · cited 3× · PMID 36685065 · DOI 10.3389/fspor.2022.1039754
Verify or expand the search:
- PubMed search for NCT03959995
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteopenia, Osteoporosis
Currently open trials in the same condition.
- NCT06851676 — Functional and Metabolic Effects of Fonte Fausta® Water on Bone and Muscle Health in Osteoporotic Patients · NA · recruiting
- NCT06018467 — Senolytics to Improve Osteoporosis Therapy · Phase 2 · active not recruiting
- NCT06781541 — Physical Activity and Disability Prevention in Postmenopausal Women · NA · active not recruiting
Other University of Erlangen-Nürnberg Medical School trials
Trials by the same sponsor.
- NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
- NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
- NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03959995 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
- Last refreshed: 9 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03959995.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing